Covington & Burling LLP advised Indivior, while Latham & Watkins LLP represented Opiant in the transaction.Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) has entered into a definitive merger…
- Homepage
- North America
- North America Legal Chronicle
- Indivior’s $145 Million Acquisition of Opiant Pharmaceuticals
Indivior’s $145 Million Acquisition of Opiant Pharmaceuticals
Tagged: 30-11-2022 Adrienne Bradley Aidan Milstead Andrew Ment Andrew Ruffino Andrew Young Ansgar Simon Betty Pang Byron Patton Christopher Drewry Colleen Smith Covington & Burling LLP Cyerra McGowan Darryl Steensma David Schindler Gabriel Gross Heather Deixler Indivior, Inc. James Barker James Dean James Marshall Jeffrey Anderson Jeffrey Lerner Jenna Wallace Jesse Lake John Manthei Jonathan Wakely Joseph Benedetto Joshua Cole Reisman Joshua Holian Julie Choi Shin Kathryn Parsons-Reponte Kristina Funahashi Latham & Watkins Laura Szarmach Matthew Piehl Max Schleusener Meryl Bartlett Michelle Carpenter Nathan Beaton Opiant Pharmaceuticals Pardis Zomorodi Ragad Alfaraidy Richard Burks Sarah Friedman Scott Ollivierre Scott Westhoff Steven Chinowsky
